| Target Professions: | DO, MD, Nurse, Nurse Practitioner, Physician Associate/Assistant |
| Target Specialties: | Obstetrics/Gynecology, Women's Health |
| Credits Available: | 4.75 hours of AMA PRA Category 1 Credit™ |
Women frequently rely on their OB/GYN as their primary source of healthcare, particularly during their reproductive years. Many of these individuals may be living with overweight or obesity, placing the OB/GYN in a uniquely positioned and trusted role to support healthy weight management and broader metabolic health goals.
Pharmacotherapy—including GLP-1 receptor agonists—can be an important tool within a comprehensive, patient-centered approach. Through this program, OB/GYNs will develop a deeper understanding of how to appropriately identify candidates for GLP-1 RA therapy across different stages of the lifespan and will learn strategies to improve patient access, streamline documentation, and optimize payor authorization and approval.
Before jumping into the activity content, reflect on your current knowledge of pharmacotherapies used to optimize women's health across the lifespan in those living with overweight or obesity.
This module will focus on the clinical benefits of GLP-1 receptor agonists and GLP-1/ GIP receptor agonists and strategies for managing common adverse events.
This module will provide a thorough overview of the use of GLP-1 RAs to optimize health across the lifespan in women who are overweight or obese.
This module focuses on patient-centered approaches for education and follow up regarding GLP-1 and GLP-1/GIP receptor agonists. Learn proven strategies for improving GLP-1 and GLP-1/GIP receptor agonist adherence and long-term outcomes.
Review what you have learned about the impact of obesity during and after the reproductive years, and how GLP‑1 RAs can support improvements in reproductive and gynecologic health. This brief assessment reinforces key concepts and adds new insights for practice.
This Live Group Discussion will focus on a case of a 36-year-old female with a history of obesity and PCOS, who has been actively trying to conceive. We will also address any questions you may have regarding the baseline and final assessments and the self-study modules.
Meet Ronnie, a 28-year-old female living with obesity and polycystic ovarian syndrome (PCOS). She presents today seeking guidance on next steps to improve her chances of conception.
In light of the information reviewed and discussed during this program, please share an action plan that you will implement to improve the diagnosis and management for your female patients with obesity
This Live Group Discussion will focus on a case of a 53-year-old female with class III obesity, hypertension, perimenopausal symptoms, along with chronic back and joint pain from a prior fracture and spinal fusion. We will also review your submissions on the Patient Case Challenge and Action Plans.
